145 related articles for article (PubMed ID: 37958891)
21. Effect of β,β-dimethylacrylshikonin on inhibition of human colorectal cancer cell growth in vitro and in vivo.
Fan Y; Jin S; He J; Shao Z; Yan J; Feng T; Li H
Int J Mol Sci; 2012; 13(7):9184-9193. PubMed ID: 22942759
[TBL] [Abstract][Full Text] [Related]
22. β,β-Dimethylacrylshikonin sensitizes human colon cancer cells to ionizing radiation through the upregulation of reactive oxygen species.
Kwak SY; Jeong YK; Kim BY; Lee JY; Ahn HJ; Jeong JH; Kim MS; Kim J; Han YH
Oncol Lett; 2014 Jun; 7(6):1812-1818. PubMed ID: 24932238
[TBL] [Abstract][Full Text] [Related]
23. Shikonin inhibits thyroid cancer cell growth and invasiveness through targeting major signaling pathways.
Yang Q; Ji M; Guan H; Shi B; Hou P
J Clin Endocrinol Metab; 2013 Dec; 98(12):E1909-17. PubMed ID: 24106286
[TBL] [Abstract][Full Text] [Related]
24. Periplocin mediates TRAIL-induced apoptosis and cell cycle arrest in human myxofibrosarcoma cells via the ERK/p38/JNK pathway.
Lohberger B; Bernhart E; Stuendl N; Glaenzer D; Leithner A; Rinner B; Bauer R; Kretschmer N
Phytomedicine; 2020 Jun; 76():153262. PubMed ID: 32559583
[TBL] [Abstract][Full Text] [Related]
25. TRAIL Enhances Shikonin Induced Apoptosis through ROS/JNK Signaling in Cholangiocarcinoma Cells.
Zhou G; Yang Z; Wang X; Tao R; Zhou Y
Cell Physiol Biochem; 2017; 42(3):1073-1086. PubMed ID: 28662515
[TBL] [Abstract][Full Text] [Related]
26. Shikonin Inhibits the Migration and Invasion of Human Glioblastoma Cells by Targeting Phosphorylated β-Catenin and Phosphorylated PI3K/Akt: A Potential Mechanism for the Anti-Glioma Efficacy of a Traditional Chinese Herbal Medicine.
Zhang FY; Hu Y; Que ZY; Wang P; Liu YH; Wang ZH; Xue YX
Int J Mol Sci; 2015 Oct; 16(10):23823-48. PubMed ID: 26473829
[TBL] [Abstract][Full Text] [Related]
27. The Critical Role of PTEN/PI3K/AKT Signaling Pathway in Shikonin-Induced Apoptosis and Proliferation Inhibition of Chronic Myeloid Leukemia.
Chen Y; Wang T; Du J; Li Y; Wang X; Zhou Y; Yu X; Fan W; Zhu Q; Tong X; Wang Y
Cell Physiol Biochem; 2018; 47(3):981-993. PubMed ID: 29843123
[TBL] [Abstract][Full Text] [Related]
28. Anti-tumor effects of shikonin derivatives on human medullary thyroid carcinoma cells.
Hasenoehrl C; Schwach G; Ghaffari-Tabrizi-Wizsy N; Fuchs R; Kretschmer N; Bauer R; Pfragner R
Endocr Connect; 2017 Feb; 6(2):53-62. PubMed ID: 28069896
[TBL] [Abstract][Full Text] [Related]
29. Cbl participates in shikonin-induced apoptosis by negatively regulating phosphoinositide 3-kinase/protein kinase B signaling.
Qu D; Xu XM; Zhang M; Jiang TS; Zhang Y; Li SQ
Mol Med Rep; 2015 Jul; 12(1):1305-13. PubMed ID: 25815461
[TBL] [Abstract][Full Text] [Related]
30. Growth inhibition and induction of apoptosis in human oral squamous cell carcinoma Tca-8113 cell lines by Shikonin was partly through the inactivation of NF-kappaB pathway.
Min R; Tong J; Wenjun Y; Wenhu D; Xiaojian Z; Jiacai H; Jian Z; Wantao C; Chenping Z
Phytother Res; 2008 Mar; 22(3):407-15. PubMed ID: 18167055
[TBL] [Abstract][Full Text] [Related]
31. Shikonin inhibits the proliferation of human lens epithelial cells by inducing apoptosis through ROS and caspase-dependent pathway.
Huang WR; Zhang Y; Tang X
Molecules; 2014 Jun; 19(6):7785-97. PubMed ID: 24962386
[TBL] [Abstract][Full Text] [Related]
32. Shikonin Inhibits Non-Small-Cell Lung Cancer H1299 Cell Growth through Survivin Signaling Pathway.
Wang H; Zuo J
Anal Cell Pathol (Amst); 2021; 2021():6435393. PubMed ID: 34782853
[TBL] [Abstract][Full Text] [Related]
33. Activation of CaMKKβ-AMPK-mTOR pathway is required for autophagy induction by β,β-dimethylacrylshikonin against lung adenocarcinoma cells.
Wang H; Zhang G
Biochem Biophys Res Commun; 2019 Sep; 517(3):477-483. PubMed ID: 31376944
[TBL] [Abstract][Full Text] [Related]
34. Shikonin inhibits gefitinib-resistant non-small cell lung cancer by inhibiting TrxR and activating the EGFR proteasomal degradation pathway.
Li X; Fan XX; Jiang ZB; Loo WT; Yao XJ; Leung EL; Chow LW; Liu L
Pharmacol Res; 2017 Jan; 115():45-55. PubMed ID: 27864022
[TBL] [Abstract][Full Text] [Related]
35. Shikonin induces apoptosis of HaCaT cells via the mitochondrial, Erk and Akt pathways.
Jing H; Sun W; Fan J; Zhang Y; Yang J; Jia J; Li J; Guo J; Luo S; Zheng Y
Mol Med Rep; 2016 Apr; 13(4):3009-16. PubMed ID: 26935874
[TBL] [Abstract][Full Text] [Related]
36. Shikonin exerts antitumor activity in Burkitt's lymphoma by inhibiting C-MYC and PI3K/AKT/mTOR pathway and acts synergistically with doxorubicin.
Ni F; Huang X; Chen Z; Qian W; Tong X
Sci Rep; 2018 Feb; 8(1):3317. PubMed ID: 29463831
[TBL] [Abstract][Full Text] [Related]
37. Shikonin inhibited mitogen-activated IL-4 and IL-5 production on EL-4 cells through downregulation of GATA-3 and c-Maf induction.
Lee CC; Kang JJ; Chiang BL; Wang CN; Cheng YW
Life Sci; 2011 Sep; 89(11-12):364-70. PubMed ID: 21806999
[TBL] [Abstract][Full Text] [Related]
38. Shikonin-induced apoptosis involves caspase-3 activity in a human bladder cancer cell line (T24).
Yeh CC; Kuo HM; Li TM; Lin JP; Yu FS; Lu HF; Chung JG; Yang JS
In Vivo; 2007; 21(6):1011-9. PubMed ID: 18210748
[TBL] [Abstract][Full Text] [Related]
39. The apoptotic effect of shikonin on human papillary thyroid carcinoma cells through mitochondrial pathway.
Liu C; Yin L; Chen J; Chen J
Tumour Biol; 2014 Mar; 35(3):1791-8. PubMed ID: 24081676
[TBL] [Abstract][Full Text] [Related]
40. Shikonin kills glioma cells through necroptosis mediated by RIP-1.
Huang C; Luo Y; Zhao J; Yang F; Zhao H; Fan W; Ge P
PLoS One; 2013; 8(6):e66326. PubMed ID: 23840441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
